TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event

Growth

William O'Neil (CAN SLIM)

14 Hits · last calculated September 18, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 14 hits from US

Methodology & criteria

O'Neil's CAN SLIM criteria ('How to Make Money in Stocks'), quantitative core: quarterly EPS and revenue each ≥ +25% (C), EPS rating ≥ 80 as evidence of multi-year earnings history (A), no more than 10% below the 52-week high (N), RS rating ≥ 80 (L), and more fund buyers than sellers in the last quarter (I). The qualitative points (new products, market direction) are checked by the investor themself, as in the original. Source: fundamental data.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(17)
52-Week High / Low
The highest or lowest price of the last 52 weeks (one trading year). "Within 10% of the 52-week high" means: the stock is trading near its yearly high - a sign of strength, since weakness looks different.
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
CANSLIM
William O'Neil's strategy framework, whose seven letters each mark a criterion - among them current earnings growth, new products/highs, institutional sponsorship, and market direction. Core idea: buy the market leaders, not the laggards.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Relative Strength (RS Rating)
How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.

View all terms in the Scanner Glossary

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

William O'Neil (CAN SLIM)
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
ATEX Anterix Inc 08/11 +51 % 61 % Stage 2 B 66 7 of 9 1.5 $ Telecom Services Neutral
Read
— Communication Services 77.40 $ +266.4 % +339.9 % +263.0 % −8.1 % +45.1 % 97 85 8.3 % 8.2 % 0.84 17.7 0.0 203.2 6.3 100.2 — -12.4 — 100.0 % 933.0 % 43.3 % -5.9 % 0.02 — +7.8 % 6 0.0 % 0.0 % 3.5 91.8 % 13.3 % 4.7 (3)
AGX Argan Inc — +629 % 76 % Stage 2 A 77 5 of 9 5.8 $ Engineering & Construction Uses AI — — Industrials 383.00 $ +135.6 % +141.6 % +60.7 % −4.8 % +49.6 % 96 86 7.0 % 7.0 % 0.57 33.8 16.6 4.9 11.2 10.6 — 23.2 15.6 % 20.7 % 15.1 % 38.5 % 10.0 % — 36.8 % +8.1 % 8 0.7 % 15.8 % 8.1 108.9 % 7.8 % 4.0 (2)
BTSG BrightSpring Health Services, Inc. 08/07 — 45 % Stage 2 B 73 8 of 9 11.2 $ Health Information Services Uses AI
Read
— Healthcare 56.60 $ +78.5 % +82.8 % +106.6 % −0.2 % +33.8 % 94 94 3.0 % 3.3 % 1.85 73.3 23.9 0.8 5.6 27.8 — 22.6 3.4 % 12.4 % 2.6 % 9.2 % 4.9 % -4.87 31.9 % +14.6 % 5 0.0 % 0.0 % 5.5 101.5 % 8.0 % 4.7 (12)
OSCR Oscar Health Inc 08/05 +84 % 69 % Stage 2 B 64 7 of 9 9.2 $ Healthcare Plans Uses AI — — Healthcare 32.00 $ +108.3 % +97.3 % +80.0 % −5.6 % -4.1 % 94 87 5.6 % 6.6 % 2.37 — 588.2 0.6 6.1 2.1 — 0.0 15.2 % 20.2 % 3.6 % -2.6 % 4.5 % 0.26 17.9 % +27.5 % 4 0.0 % 0.0 % 3.0 67.6 % 6.5 % 3.3 (7)
NESR National Energy Services Reunited Corp. 08/19 +252 % 55 % Stage 2 B 69 7 of 9 3.3 $ Oil & Gas Equipment & Services Neutral
Read
— Energy 32.50 $ +60.1 % +89.1 % +208.3 % −2.6 % +33.2 % 94 87 5.7 % 5.1 % 0.40 50.0 0.0 2.0 3.2 14.2 — 11.8 8.9 % 13.3 % 5.8 % 6.7 % 4.8 % 0.31 51.7 % +1.7 % 7 0.0 % 0.0 % 5.0 85.2 % 5.2 % 4.3 (3)
NAT Nordic American Tankers Limited — +50 % 39 % Stage 2 B 67 4 of 9 1.7 $ Oil & Gas Midstream Neutral
Read
— Energy 8.20 $ — — +185.0 % −0.7 % -20.7 % 92 97 5.9 % 4.4 % -0.52 30.1 14.0 5.2 3.6 — 1.21 12.2 49.5 % 53.2 % 33.3 % 11.4 % 7.2 % 0.95 49.4 % -16.4 % 3 13.8 % 1.7 % 2.5 56.7 % 8.1 % 3.7 (3)
TGTX TG Therapeutics Inc 08/03 +43 % 45 % Stage 2 B 65 5 of 9 8.7 $ Biotechnology Neutral
Read
— Healthcare 56.50 $ +80.9 % +79.3 % +76.3 % −6.5 % +23.4 % 90 92 5.0 % 4.8 % 1.66 20.3 24.6 10.9 15.2 498.6 1.61 59.7 17.0 % 82.4 % 55.2 % 112.6 % 7.3 % 1.29 38.1 % +87.3 % 6 0.0 % 0.0 % 6.2 70.2 % 28.5 % 4.3 (9)
VIRT Virtu Financial, Inc. 07/29 +98 % 35 % Stage 2 B 55 3 of 9 12.3 $ Capital Markets – — — Financial Services 57.30 $ +92.3 % +74.0 % +66.3 % −5.9 % +16.4 % 89 83 4.6 % 3.8 % 0.62 9.3 9.8 3.0 2.8 25.5 — 6.5 46.8 % 65.8 % 16.9 % 56.9 % 4.5 % 2.68 6.9 % +26.3 % 4 1.7 % 14.6 % 4.7 92.4 % 6.5 % 3.3 (9)
ASTH Astrana Health Inc 08/06 +13 % 68 % Stage 2 B 62 5 of 9 1.7 $ Medical Care Facilities Uses AI
Read
— Healthcare 34.30 $ +66.1 % +79.3 % +18.0 % −0.5 % +50.6 % 89 87 3.6 % 3.8 % 0.91 — 23.0 0.4 — 18.0 — 13.0 3.0 % 10.5 % 1.1 % 5.7 % 3.8 % — 33.9 % +56.4 % 5 0.0 % 0.0 % 5.2 61.5 % 12.6 % 4.5 (12)
AMN AMN Healthcare Services Inc 08/06 -23 % 65 % Stage 2 B 55 8 of 9 1.3 $ Medical Care Facilities Threatened
Read
— Healthcare 34.60 $ +98.2 % +102.2 % +81.8 % −2.4 % +4.5 % 89 93 4.9 % 5.2 % 0.39 — 18.0 0.4 — 3.0 1.71 5.0 — 27.8 % 3.1 % -4.5 % 4.4 % — — -8.5 % 2 0.0 % 0.0 % 5.6 115.6 % 10.5 % 3.3 (9)
PTGX Protagonist Therapeutics Inc 08/05 +110 % 48 % Stage 2 B 64 6 of 9 9.2 $ Biotechnology – — — Healthcare 143.70 $ +36.2 % +36.9 % +142.7 % −2.8 % +21.6 % 87 94 4.2 % 4.5 % 1.79 — 36.9 32.7 14.3 69.7 — 142.2 -6.5 % 100.0 % 29.4 % -17.1 % 4.6 % 0.02 94.0 % -89.4 % 4 0.0 % 0.0 % 21.8 125.3 % 13.9 % 4.4 (10)
RSI Rush Street Interactive Inc 07/29 +294 % 50 % Stage 2 B 71 6 of 9 6.1 $ Gambling Uses AI
Read
— Consumer Cyclical 25.30 $ +51.9 % +63.0 % +19.3 % −2.2 % +42.3 % 86 81 4.7 % 4.0 % 1.51 73.7 33.9 4.4 16.2 35.5 — 14.9 11.6 % 35.0 % 2.3 % 34.7 % 12.8 % 0.04 23.5 % +22.8 % 6 0.0 % 0.0 % 5.4 100.5 % 6.9 % 4.9 (7)
DAVE Dave Inc 08/05 +2,117 % 70 % Stage 2 B 74 6 of 9 4.5 $ Software - Application Uses AI
Read
— Technology 356.50 $ +43.6 % +62.5 % +63.0 % −5.8 % +24.6 % 83 86 8.5 % 8.1 % 3.84 — 17.9 7.0 — 13.8 — 21.6 38.3 % 71.8 % 34.6 % 111.6 % 31.0 % — 38.4 % +59.7 % 9 0.0 % 0.0 % 11.6 100.1 % 21.5 % 4.8 (8)
CXW CoreCivic Inc 08/05 +72 % 39 % Stage 2 B 64 7 of 9 3.5 $ Security & Protection Services – — — Industrials 35.50 $ +55.6 % +58.6 % +71.9 % −4.5 % +17.7 % 83 81 4.2 % 4.0 % 0.60 30.4 13.8 1.4 2.6 36.0 1.06 12.4 11.4 % 22.6 % 5.1 % 9.0 % 4.8 % 1.00 41.4 % +12.7 % 3 0.0 % 0.0 % 5.3 91.6 % 17.8 % 5.0 (4)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

O'Neil's CAN SLIM criteria ('How to Make Money in Stocks'), quantitative core: quarterly EPS and revenue each ≥ +25% (C), EPS rating ≥ 80 as evidence of multi-year earnings history (A), no more than 10% below the 52-week high (N), RS rating ≥ 80 (L), and more fund buyers than sellers in the last quarter (I).

All scanners are recalculated daily across the entire stock universe — most recently on September 18, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 14 stocks pass this scanner's criteria (as of September 18, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?